National Evaluation of Hospital Performance on the New Commission on Cancer Melanoma Quality Measures

[1]  Kendra Johnson,et al.  Integration of and adherence to National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) in a Community Cancer Center , 2015 .

[2]  B. Barber,et al.  Treatment patterns in advanced melanoma: findings from a survey of European oncologists. , 2015, European journal of cancer care.

[3]  D. Fraker,et al.  The rise in metastasectomy across cancer types over the past decade , 2015, Cancer.

[4]  M. Schön,et al.  Sentinel Node Biopsy Improves Prognostic Stratification in Patients with Thin (pT1) Melanomas and an Additional Risk Factor , 2014, Annals of Surgical Oncology.

[5]  R. Elashoff,et al.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma. , 2014, The New England journal of medicine.

[6]  Benjamin S. Kester,et al.  An Opportunity to Ensure High-Quality Melanoma Care Through the Use of a Preoperative Treatment Algorithm , 2013, Annals of Surgical Oncology.

[7]  G. Eslick,et al.  Is complete lymph node dissection after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? A meta-analysis. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  G. Lyman,et al.  Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline , 2012, Annals of Surgical Oncology.

[9]  R. Gutzmer,et al.  Age as a key factor influencing metastasizing patterns and disease‐specific survival after sentinel lymph node biopsy for cutaneous melanoma , 2011, International journal of cancer.

[10]  V. Sondak,et al.  Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  M. Shoup,et al.  Predictors of positive sentinel lymph node in thin melanoma. , 2011, American journal of surgery.

[12]  Jeffrey E Gershenwald,et al.  Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  C. Ko,et al.  National assessment of melanoma care using formally developed quality indicators. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  C. Ko,et al.  Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Ross,et al.  Lymph node ratio predicts disease‐specific survival in melanoma patients , 2009, Cancer.

[16]  C. Balch,et al.  Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  K. Shannon,et al.  Proposed Quality Standards for Regional Lymph Node Dissections in Patients With Melanoma , 2009, Annals of surgery.

[18]  J. Feinglass,et al.  Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  A. Kielar,et al.  PET vs sentinel lymph node biopsy for staging melanoma: a patient intervention, comparison, outcome analysis. , 2008, Journal of the American College of Radiology : JACR.

[20]  C. Ko,et al.  Complete Lymph Node Dissection for Sentinel Node-Positive Melanoma: Assessment of Practice Patterns in the United States , 2008, Annals of Surgical Oncology.

[21]  C. Ko,et al.  The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States , 2008, Annals of Surgical Oncology.

[22]  R. Cecchi,et al.  Sentinel lymph node biopsy in patients with thin melanomas , 2007, The Journal of dermatology.

[23]  V. Sondak,et al.  Chemotherapy for metastatic melanoma , 2007, Cancer.

[24]  N. Cascinelli,et al.  Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  H. Hoekstra,et al.  Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[26]  D. Coit,et al.  Results of Sentinel Lymph Node Biopsy in Patients With Thin Melanoma , 2006, Annals of Surgical Oncology.

[27]  D. Morton,et al.  Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  R. Scolyer,et al.  The Prognostic Importance of Tumor Mitotic Rate Confirmed in 1317 Patients With Primary Cutaneous Melanoma and Long Follow-Up , 2004, Annals of Surgical Oncology.

[29]  M. Walker,et al.  Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. , 2003, Surgery.

[30]  D. Morton,et al.  Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Martin F. Mihm,et al.  Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.